Sales Of Nerve Repair And Regeneration Devices Are Set To Increase At 11% CAGR Through 2026

Nerve Repair and Regeneration Market Analysis By Product (Neurostimulation & Neuromodulation Devices and Biomaterials) By Application (Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting & Stem Cell Therapy) By End-User & Region – Insights 2022 to 2

    • Renerva is an innovative medical device start-up based in the U.S. that joined Cornell University’s McGovern Center life sciences business. Renerva is developing an over-the-counter nerve transplant product that could prevent individuals from suffering from permanent disability and improving an injectable gel to speed up the regeneration of damaged nerves.

By Product :

    • Neurostimulation Neuromodulation Devices

By Application :

    • Neurostimulation Neuromodulation Surgeries
    • Neurorrhaphy
    • Nerve Grafting
    • Stem Cell Therapy

By End User :

    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers

By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East Africa

 

    • Scientists at the Mayo Clinic are developing a cell-based treatment for the neurodegenerative condition amyotrophic lateral sclerosis. They hope to do this by using a patient’s own adipose-derived mesenchymal stem cells, modifying them in a lab, and then reintroducing them into the person’s body.
    • Baxter
    • Polyganics B.V.
    • Nevro
    • Stryker
      • Abbott Laboratories
    • AxoGen, Inc.
    • Boston Scientific Corporation
    • Integra LifeSciences Corporation
    • LivaNova, PLC
    • Global nerve repair and regeneration market to Market in Canada expected to rise at 9% CAGR from 2022 to 2026.
    • Market in Germany set to expand at 9.5% CAGR over the forecast period.
    • Demand for neurostimulation neuromodulation devices projected to rise at 9.5% CAGR through 2026.

FactmrPrashil

53 Blog posts

Comments